Beyond the seizures: Ketogenic Diets in the battle against drug-resistant epilepsy
DOI:
https://doi.org/10.12775/JEHS.2025.77.56870Keywords
drug-resistant epilepsy, ketogenic diet, diet in drug-resistant epilepsyAbstract
Introduction: Epilepsy is a chronic, non-infectious and one of the most common neurological disease. About 70 million people worldwide suffer from it and these are patients of all ages. Despite the existence of many anticonvulsants and multiple lines of treatment, some patients still experience symptoms of the epilepsy. International league against epilepsy says that one-third of people with epilepsy fail to control it with anti-epileptic drugs (AED) and continue to have seizures.
Purpose: The aim of the study is to analyze the impact of using a ketogenic diet in patients with epilepsy that meets the criteria for drug-resistant epilepsy.
Materials and method: In April 2024, articles found in the Medline (Pubmed) databases were selected by using the following keywords: ketogenic diet in drug-resistant epilepsy, drug-resistant epilepsy, ketogenic diet and selected articles from 2018-2023.
Conclusions: In the ketogenic diet, ketones formed from the oxidation of fatty acids are the source of energy instead of glucose. Ketones increase the amount of inhibitory neurotransmitters and glutathione. It improves neuronal hemostasis and increases cells’ resistance during excessive electrical discharges in the brain. These qualities are responsible for the antiepileptic profile of the ketogenic diet. Patients who follow a ketogenic diet experience fewer seizures attacks. We do not know the long-term side effects of the ketogenic diet yet and it is impossible to make a definitive thesis. Scientists are working to prove the validity of ketogenic diet in drug-resistant epilepsy.
References
Ułamek-Kozioł M, Czuczwar SJ, Pluta R, Januszewski S. Ketogenic Diet and Epilepsy. Nutrients. 2019;11(10). doi:10.3390/NU11102510
Epilepsy. WHO. World Health Organization site. https://www.who.int/news-room/fact-sheets/detail/epilepsy (Published February 9, 2023 Accessed July 5, 2023).
Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2020;54(2):185-191. doi:10.1159/000503831
Bazhanova ED, Kozlov AA, Litovchenko A V. Mechanisms of Drug Resistance in the Pathogenesis of Epilepsy: Role of Neuroinflammation. A Literature Review. Brain Sci. 2021;11(5). doi:10.3390/BRAINSCI11050663
What Is Epilepsy? | Epilepsy Foundation. https://www.epilepsy.com/what-is-epilepsy (Accessed July 5, 2023).
Types of Seizures | Epilepsy | CDC. Centers for Disease Control and Prevention. https://www.cdc.gov/epilepsy/about/types-of-seizures.htm (Page last Reviewed
September 30, 2020 Accessed July 5, 2023).
Hwang BY, Xu R. Seizure. The Neurosurgical Consult Book. Published online February 7, 2023:152-155. doi:10.1016/B978-0-323-75614-3.00030-3
Seizure Medicines | Epilepsy Foundation. https://www.epilepsy.com/treatment/medicines#Medicine-Is-The-Most-Common-Way-Of-Treating-Epilepsy-And-Is-Almost-Always-The-First-Treatment-Tried
(Accessed July 5, 2023).
Corrales-Hernández MG, Villarroel-Hagemann SK, Mendoza-Rodelo IE, et al. Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence. Biomedicines. 2023;11(6). doi:10.3390/BIOMEDICINES11061632
Epilepsy - Treatment - NHS. https://www.nhs.uk/conditions/epilepsy/treatment/ (Page last Reviewed September 18, 2020 Accessed July 5, 2023).
Padaczka lekooporna | Neurologia Praktyczna. https://neurologia-praktyczna.pl/a1321/padaczka-lekooporna.html (Accessed July 5, 2023).
Nevitt SJ, Sudell M, Cividini S, Marson AG, Tudur Smith C. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2022;4(4). doi:10.1002/14651858.CD011412.PUB4
Kalilani L, Sun X, Pelgrims B, Noack-Rink M, Villanueva V. The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis. Epilepsia. 2018;59(12):2179-2193. doi:10.1111/EPI.14596
Xue-Ping W, Hai-Jiao W, Li-Na Z, Xu D, Ling L. Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis. Medicine. 2019;98(30). doi:10.1097/MD.0000000000016402
Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-1077. doi:10.1111/J.1528-1167.2009.02397.X
Tran VD, Nguyen BT, Van Dong H, et al. Microsurgery for drug resistance epilepsy due to temporal lobe lesions in a resource limited condition: a cross-sectional study. Ann Med Surg (Lond). 2023;85(8):3852-3857. doi:10.1097/MS9.0000000000001021
Sharma S, Whitney R, Kossoff EH, RamachandranNair R. Does the ketogenic ratio matter when using ketogenic diet therapy in pediatric epilepsy? Epilepsia. 2023;64(2):284-291. doi:10.1111/EPI.17476
Pietrzak D, Kasperek K, Rękawek P, Piątkowska-Chmiel I. The Therapeutic Role of Ketogenic Diet in Neurological Disorders. Nutrients. 2022;14(9). doi:10.3390/NU14091952
Barzegar M, Afghan M, Tarmahi V, Behtari M, Rahimi Khamaneh S, Raeisi S. Ketogenic diet: overview, types, and possible anti-seizure mechanisms. Nutr Neurosci. 2021;24(4):307-316. doi:10.1080/1028415X.2019.1627769
Sondhi V, Agarwala A, Pandey RM, et al. Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial. JAMA Pediatr. 2020;174(10):944-951. doi:10.1001/JAMAPEDIATRICS.2020.2282
Wells J, Swaminathan A, Paseka J, Hanson C. Efficacy and Safety of a Ketogenic Diet in Children and Adolescents with Refractory Epilepsy-A Review. Nutrients. 2020;12(6):1-19. doi:10.3390/NU12061809
Zarnowska IM. Therapeutic Use of the Ketogenic Diet in Refractory Epilepsy: What We Know and What Still Needs to Be Learned. Nutrients. 2020;12(9):1-23. doi:10.3390/NU12092616
Mentzelou M, Dakanalis A, Vasios GK, Gialeli M, Papadopoulou SK, Giaginis C. The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice. Nutrients. 2023;15(10). doi:10.3390/NU15102270
Pondel N, Liśkiewicz D, Liśkiewicz A. [Ketogenic diet – mechanism of action and perspectives for the use in the therapy: data from clinical studies]. Postepy Biochem. 2020;66(3). doi:10.18388/PB.2020_342
Simeone TA, Simeone KA, Stafstrom CE, Rho JM. Do ketone bodies mediate the anti-seizure effects of the ketogenic diet? Neuropharmacology. 2018;133:233-241. doi:10.1016/J.NEUROPHARM.2018.01.011
Sourbron J, Klinkenberg S, van Kuijk SMJ, et al. Ketogenic diet for the treatment of pediatric epilepsy: review and meta-analysis. Childs Nerv Syst. 2020;36(6):1099-1109. doi:10.1007/S00381-020-04578-7
Operto FF, Labate A, Aiello S, et al. The Ketogenic Diet in Children with Epilepsy: A Focus on Parental Stress and Family Compliance. Nutrients. 2023;15(4). doi:10.3390/NU15041058
Gough SM, Casella A, Ortega KJ, Hackam AS. Neuroprotection by the Ketogenic Diet: Evidence and Controversies. Front Nutr. 2021;8. doi:10.3389/FNUT.2021.782657
Cicek E, Sanlier N. The place of a ketogenic diet in the treatment of resistant epilepsy: a comprehensive review. Nutr Neurosci. 2023;26(9):828-841. doi:10.1080/1028415X.2022.2095819
El-Rashidy OF, Nassar MF, Shokair WA, El Gendy YGA. Ketogenic diet for epilepsy control and enhancement in adaptive behavior. Sci Rep. 2023;13(1). doi:10.1038/S41598-023-27373-1
Ketogenic Diet for Seizures | Epilepsy Foundation.
https://www.epilepsy.com/treatment/dietary-therapies/ketogenic-diet (Page last Reviewed October 25, 2017 Accessed July 6, 2023).
Dieta pomagająca w padaczce | Pacjent. https://pacjent.gov.pl/diety/dieta-pomagajaca-w-padaczce (Published Agust 25, 2020 Accessed July 7, 2023).
D’Andrea Meira I, Romão TT, Do Prado HJP, Krüger LT, Pires MEP, Da Conceição PO. Ketogenic Diet and Epilepsy: What We Know So Far. Front Neurosci. 2019;13(JAN). doi:10.3389/FNINS.2019.00005
Liu H, Yang Y, Wang Y, et al. Ketogenic diet for treatment of intractable epilepsy in adults: A meta-analysis of observational studies. Epilepsia Open. 2018;3(1):9-17. doi:10.1002/EPI4.12098
Ruiz Herrero J, Cañedo Villarroya E, García Peñas JJ, et al. [Ketogenic dietary therapies for epilepsy: Experience in 160 patients over 18 years]. An Pediatr (Engl Ed). 2021;96(6):511-522. doi:10.1016/j.anpedi.2021.05.006
Pizzo F, Collotta AD, Di Nora A, Costanza G, Ruggieri M, Falsaperla R. Ketogenic diet in pediatric seizures: a randomized controlled trial review and meta-analysis. Expert Rev Neurother. 2022;22(2):169-177. doi:10.1080/14737175.2022.2030220
Lyons L, Schoeler NE, Langan D, Cross JH. Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. 2020;61(6):1261-1281. doi:10.1111/EPI.16543
Yılmaz Ü, Edizer S, Akışin Z, et al. The effectiveness of the ketogenic diet in drug-resistant childhood epilepsy. Turk J Pediatr. 2022;64(2):210-220. doi:10.24953/TURKJPED.2021.4
Kumar G. Evaluation and management of drug resistant epilepsy in children. Curr Probl Pediatr Adolesc Health Care. 2021;51(7):101035. doi:10.1016/J.CPPEDS.2021.101035
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Natalia Domańska, Małgorzata Bojarska, Julia Bogucka, Anna Brzyska, Michalina Kosowska, Halina Piecewicz-Szczęsna
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 145
Number of citations: 0
